Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-21

Clinical Trial Update: A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two fixed-dose combination eye drops, DuoTrav (travoprost/timolol) and Xalacom (latanoprost/timolol), in open-angle glaucoma and ocula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DuoTrav (travoprost; timolol (fixed-dose combination))
  • Xalacom (latanoprost/timolol)

Snippet

Sponsor: Ophthalmic Consultants Centres, Canada | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED